Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-7-27
|
pubmed:language |
por
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0035-0362
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2471993-Adenocarcinoma,
pubmed-meshheading:2471993-Antibodies, Monoclonal,
pubmed-meshheading:2471993-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:2471993-Epitopes,
pubmed-meshheading:2471993-Female,
pubmed-meshheading:2471993-Humans,
pubmed-meshheading:2471993-Ovarian Neoplasms
|
pubmed:articleTitle |
[The dosage of CA 125 in carcinoma of the ovary and other solid neoplasms].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|